FDA allows marketing of first whole slide imaging system for digital pathology - FDA Press Releases

The U.S. Food and Drug Administration today permitted marketing of the Philips IntelliSite Pathology Solution (PIPS), the first whole slide imaging (WSI) system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue. This is the first time the FDA has permitted the marketing of a WSI system for these purposes.

from Food and Drug Administration--Press Releases http://ift.tt/2oAd6I4
via IFTTT